← SynDRA

goserelin

SynDRA canonical compound SYN0041808 — structure-anchored drug synonym record

All known targets

• GNRHR
• GNRH1
• LHCGR

Mechanisms of action (all sources)

• Gonadotropin releasing factor hormone receptor agonist
• GNRHR AGONIST
• Gonadotropin-releasing hormone receptor agonist
• GNRH1 ACTIVATOR

Drug classes

• Gonadotropin Releasing Hormone Receptor Agonists
• Gonadotropin Releasing Hormone Receptor Agonist
• Antineoplastic Agents
• Antineoplastic Agents, Hormonal

ATC classes

• L02A · HORMONES AND RELATED AGENTS

Cross-references

• PubChem CID: 5311128
• ChEMBL: CHEMBL1201247
• DrugBank: DB00014
• ChEBI: CHEBI:5523
• KEGG: D00573
• RxNorm: 50610
• Wikipedia: Goserelin
• TTD: D00BCG
• LINCS BRD: BRD-K99504665

Synonyms

• Decapeptide I
• zoladex
• goserelin acetate
• Gosereline
• Goserelina
• ICI 118,630
• ICI-118630
• AstraZeneca (TN)
• HS-2015
• ZD-9393
• Zoladex (TN)
• goserelin-acetate
• 0F65R8P09N
• goserelin (ep monograph)
• ICI 118630
• Goserelinum
• ICI118630
• Acetate, Goserelin
• RefChem:57538
• DTXCID2028272
• L02AE03
• Gosereline [French]
• Goserelinum [Latin]
• Goserelina [Spanish]
• Goserelin [USAN:INN:BAN]
• UNII-0F65R8P09N
• Goserelin Acetate
• Goserelin CRS
• HSDB 7606
• C59H84N18O14
• MFCD00867894
• GOSERELIN [INN]
• GOSERELIN [MI]
• Goserelin (USAN/INN)
• GOSERELIN [HSDB]
• GOSERELIN [USAN]
• D-Ser(t-Bu)(sup 6)aza-gly(sup 10)-GNRH
• GOSERELIN [MART.]

Reported adverse events

• Headache
• Injection site reaction
• Rash
• Psychotic disorder
• Acne
• Asthenia
• Cystitis
• Depression
• Dizziness
• Hypertension
• Hypertonia
• Hypotension